Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
Journal of Virology · 2023
DOI: 10.1128/jvi.00771-23 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Journal of Virology, 2023. Verfasst von Yannic C Bartsch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ragon Institute of MGH, MIT, and Harvard , Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals.
Abstract (Originalsprache)
An Ad26.RSV.preF/RSV preF protein combination vaccine demonstrated 80.0% vaccine efficacy for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in a phase 2b study. In addition to neutralizing antibodies, Fc-effector functions are associated with protective immunity against RSV. Here, vaccine-induced Fc-effector functions were evaluated for the Ad26.RSV.preF/RSV preF protein vaccine in a subset of participants enrolled in a phase 1/2a study. RSV preF-specific antibody subclasses, isotypes, Fcγ receptor binding, and Fc-effector functions were evaluated on days 1 (pre-vaccination), 15, 29, and 183. Compared with Ad26.RSV.preF or RSV preF protein alone, the combination vaccine induced greater Fc-effector functions, including antibody-dependent neutrophil phagocytosis and antibody-dependent natural killer cell activation. Despite RSV pre-exposure, antibody-dependent neutrophil phagocytosis and antibody-dependent natural killer cell activation were not observed at baseline but were induced de novo following vaccination. Compared with the individual vaccine components, the combination vaccine induced a more polyfunctional antibody response. IMPORTANCE Respiratory syncytial virus (RSV) can cause serious illness in older adults (i.e., those aged ≥60 years). Because options for RSV prophylaxis and treatment are limited, the prevention of RSV-mediated illness in older adults remains an important unmet medical need. Data from prior studies suggest that Fc-effector functions are important for protection against RSV infection. In this work, we show that the investigational Ad26.RSV.preF/RSV preF protein vaccine induced Fc-effector functional immune responses in adults aged ≥60 years who were enrolled in a phase 1/2a regimen selection study of Ad26.RSV.preF/RSV preF protein. These results demonstrate the breadth of the immune responses induced by the Ad26.RSV.preF/RSV preF protein vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ragon Institute of MGH, MIT, and Harvard , Cambridge, Massachusetts, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology , Cambridge, Massachusetts, USA.
- Janssen Vaccines & Prevention B.V. , Leiden, South Holland, the Netherlands.
- Janssen Infectious Diseases , Beerse, Belgium.
ORCID-Profile: Yannic C Bartsch
Förderung
- Janssen Pharmaceuticals
Zitieren
APA
Bartsch, Y. C., Cizmeci, D., Yuan, D., Mehta, N., Tolboom, J., De Paepe, E., van Heesbeen, R., Sadoff, J., Comeaux, C. A., Heijnen, E., Callendret, B., Alter, G., & Bastian, A. R. (2023). Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine. Journal of Virology. https://doi.org/10.1128/jvi.00771-23
Vancouver
Bartsch YC, Cizmeci D, Yuan D, Mehta N, Tolboom J, De Paepe E, et al. Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine. Journal of Virology. 2023. doi:10.1128/jvi.00771-23
BibTeX
@article{Bartsch2023,
author = {Bartsch, Yannic C and Cizmeci, Deniz and Yuan, Dansu and Mehta, Nickita and Tolboom, Jeroen and De Paepe, Els and van Heesbeen, Roy and Sadoff, Jerald and Comeaux, Christy A and Heijnen, Esther and Callendret, Benoit and Alter, Galit and Bastian, Arangassery Rosemary},
title = {Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.00771-23}
}
EUVIMED